Please assess the completion status of the following clinical trial:

Trial Title: Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* subjects with neurogenic bladders secondary to spinal cord injury~Exclusion Criteria:~* prior augmentation procedures or urinary diversion~* recent urologic or intraperitoneal surgery or device implantation~* recent history of spinal cord injury of less than a year~* recent neurologic surgery~* requirement for concomitant urological surgical procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Receipt of autologous neo-bladder construct consisting of a device regenerated in the laboratory from the patient's own muscle and urothelial cells

Based on this trial design, predict the completion outcome and termination type (if applicable).